SAB Biotherapeutics SABS Q3 2025 earnings
Reported November 14, 2025 · Before market open
EPS-$0.21Beat by $0.38
Revenue estimate$100.0K
EPS estimate-$0.59
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$125.0K
EPS estimate-$0.29
Versus estimates
Revenue
Diluted EPS
Ask the moment SAB Biotherapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did SAB Biotherapeutics report Q3 2025 earnings?
- SAB Biotherapeutics (SABS) reported Q3 2025 earnings on November 14, 2025 before market open.
- What were SAB Biotherapeutics's Q3 2025 revenue and EPS?
- SAB Biotherapeutics reported eps of $-0.21 for Q3 2025.
- Did SAB Biotherapeutics beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-0.59 by $0.38.
- How did SAB Biotherapeutics's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 81.3% from $-1.12.
- Where can I find SAB Biotherapeutics's Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001193125-25-280572) directly on SEC EDGAR. The filing index links above go to sec.gov.